High 18F-FDG Uptake in a Papillary Craniopharyngioma of the Third Ventricle.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000004562
Abstract: ABSTRACT Craniopharyngioma is a benign tumor classified as grade 1 by the World Health Organization Classification of Tumors of the Central Nervous System. We present a rare case of a high-18F-FDG-avidity papillary craniopharyngioma of the… read more here.
Keywords: high 18f; third ventricle; craniopharyngioma; papillary craniopharyngioma ... See more keywords
BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors.
Sign Up to like & getrecommendations! Published in 2017 at "CNS oncology"
DOI: 10.2217/cns-2016-0034
Abstract: We present a patient with BRAF-V600E mutant papillary craniopharyngioma successfully treated with combination BRAF (dabrafenib 150 mg twice daily) and MEK (trametinib 2 mg daily) inhibitors after her unresectable tumor proved refractory to radiation. Serial… read more here.
Keywords: braf v600e; mutant papillary; braf; combination braf ... See more keywords
Current Advances in Papillary Craniopharyngioma: State-Of-The-Art Therapies and Overview of the Literature
Sign Up to like & getrecommendations! Published in 2023 at "Brain Sciences"
DOI: 10.3390/brainsci13030515
Abstract: Craniopharyngiomas are commonly classified as low-grade tumors, although they may harbor a malignant behavior due to their high rate of recurrence and long-term morbidity. Craniopharyngiomas are classically distinguished into two histological types (adamantinomatous and papillary),… read more here.
Keywords: craniopharyngioma state; state art; craniopharyngioma; papillary craniopharyngioma ... See more keywords